- CtDNA dynamic detection reflects the clinical efficacy following treatment in NSCLC patients.Feng, Wei-Neng; Gu, Weiguang; Zhang, Hua; Lu, Yiyu; Gu, Weiquan; Li, Minjing; Yang, Shuang; Ye, Zhijian; Liu, Jian; Lin, Qing; Liang, Yaojun; Chen, Haiming; Shi, Xiaoliang; You, DongAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), ELECTR NETWORK, 2022-06-03 To 2022-06-07.
- 23P Clinical utility of cell free DNA in pleural lavage and plasma in resectable NSCLC: A pilot studySaikia J.; Malik P.; Jain D.; Kumar S.; Bharati S.; Madan K.; Gamit P.; Deo S.V.S.; Kumar S.Journal of Thoracic Oncology, 2021, 16(4S).
- Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung CancerBruna Pellini; Jeffrey Szymanski; Re-I. Chin; Paul A. Jones; Aadel A. ChaudhuriThoracic Surgery Clinics, 2020, 30(2): 165-177.
期刊论文
163P Circulating tumour (ct) DNA next generation sequencing (NGS) in UK advanced non-small cell lung cancer (aNSCLC) patients (pts)
23阅读
